Cited by 291Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional DevelopmentAutism Spectrum Disorder Research

Adult Outcome of Attention-Deficit/Hyperactivity Disorder: A Controlled 16-Year Follow-Up Study

Open access
Biederman, Joseph, Petty, Carter R., Woodworth, K. Yvonne, Lomedico, Alexandra, Hyder, Laran L., Faraone, Stephen V.·2012·The Journal of Clinical Psychiatry

Abstract

OBJECTIVE: To estimate the risks for psychopathology and functional impairments in adulthood among a longitudinal sample of youth with and without attention-deficit/hyperactivity disorder (ADHD) diagnosed in childhood. METHOD: This was a case-controlled, 16-year (15-19 years) prospective follow-up study of ADHD. 140 boys with and 120 without DSM-III-R ADHD were recruited from pediatric and psychiatric settings. The main outcome measures were structured diagnostic interviews and measures of psychosocial, educational, and neuropsychological functioning. Data were collected from 1988 to 2006. RESULTS: At the 16-year follow-up, subjects with ADHD continued to significantly differ from controls in lifetime rates of antisocial, mood, anxiety, and addictive disorders, but with the exception of a higher interval prevalence of anxiety disorders (20% vs 8%; z = 2.32, P = .02) and smoking dependence (27% vs 11%; z = 2.30, P = .02), the incidence of individual disorders in the 6-year interval between the current and prior follow-up did not differ significantly from controls. At follow-up, the ADHD subjects compared with controls were significantly (P < .05) more impaired in psychosocial, educational, and neuropsychological functioning, differences that could not be accounted for by other active psychopathology. CONCLUSIONS: These long-term prospective findings provide further evidence for the high morbidity associated with ADHD across the life cycle, stressing the importance of early recognition of this disorder for prevention and early intervention strategies. These findings also indicate that, in adulthood, ADHD confers significant risks for impairment that cannot be accounted for by other psychopathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.11m07529

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Improvements observed from LDX versus placebo in this trial were comparable to those observed in LDX interventions for adults with ADHD.

    “Improvements observed from LDX versus placebo in this trial were comparable to those observed in LDX interventions for adults with ADHD [16,27–29].”

    From Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine (2024) · cites this paper as [29]

    The Discussion and Functional, Educational, Occupational, and Cognitive Outcomes sections describe a 16-year follow-up comparing men who had ADHD as boys with controls. Searches for LDX, lisdexamfetamine, placebo, and adult treatment trials found no passage reporting LDX-versus-placebo improvements or a comparison with such interventions. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • In placebo-controlled LDX trials in ADHD, participants were considered treatment responders if they had a ≥ 30% reduction in ADHD symptoms using a standardized scale.

    “in placebo-controlled LDX trials in ADHD, participants were considered treatment “responders” if they had a ≥ 30% reduction in ADHD symptoms using a standardized scale [27–29].”

    From Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine (2024) · cites this paper as [29]

    The Follow-Up Assessment Procedures section defines persistent and subthreshold ADHD for a 16-year follow-up study, not treatment response in a placebo-controlled trial. Searches for LDX, lisdexamfetamine, and a 30% symptom-reduction responder threshold found no passage addressing the claim. Page numbers were not available in our copy. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • Follow-ups of clinical childhood-ADHD samples have not yielded many participants who meet adult-ADHD criteria.

    “Moreover, follow-ups of clinical childhood-ADHD samples have not yielded many participants who meet adult-ADHD criteria(3-6).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 38 · Cited by 291

Research works printed but not linked: 9

  1. Hechtman L, Weiss G, Perlman T. Young adult outcome of hyperactive children who received long-term stimulant treatment. J Am Acad Child Psychiatry. 1984;23(3):261-269. d o i : 1 0 . 1 0 1 6 / S 0 0 0 2 -7 1 3 8 ( 0 9 ) 6 0 5 -X P u b M e d 2. Loney J, Kramer J, Milich RS. The hyperactive child grows up: predictors of symptoms, delinquency and achievement at follow-up. In: Gadow KD, Loney J, eds. Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, CO: Westview Press; 1981:381-416.
  2. P u b M e d 4. Gittelman R, Mannuzza S, Shenker R, et al. Hyperactive boys almost grown up, 1: psychiatric status. Arch Gen Psychiatry. 1985;42(10): 937-947.
  3. Satterfield JH, Faller KJ, Crinella FM, et al. A 30-year prospective follow- up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry. 2007;46(5):601-610. d o i : 1 0 . 1 0 9 7 / c h i . 3 1 8
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
  5. Moos RH, Moos BS. Manual for the Family Environment Scale. Palo Alto, CA: Consulting Psychologists Press; 1974.
  6. P u b M e d For the CME Posttest for this article, see pages 951-952.
  7. P u b M e d 49. Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524-540. d o i : 1 0 . 4 0 8 8 / J C P . v 6 7 n 0 4 0 3 P u b M e d
  8. Halmøy A, Fasmer OB, Gillberg C, et al. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13(2):175-187. d o i : 1 0 . 1 1 7 7 / 1 0 8 7 0 5 4 7 0 8 3 2 9 7
  9. P u b M e d 51. Bender BG, Iklé DN, DuHamel T, et al. Retention of asthmatic patients in a longitudinal clinical trial. J Allergy Clin Immunol. 1997;99(2):197-203. d o i : 1 0 . 1 0 1 6 / S 0 0 9 1 -6 7 4 9 ( 9 7 ) 7 0 0 9 6 -4 P u b M e d

Authors
Biederman, J., Petty, C. R., Woodworth, K. Y., Lomedico, A., Hyder, L. L., & Faraone, S. V.
Affiliations
  • Massachusetts General Hospital (US)
  • SUNY Upstate Medical University (US)
Corresponding author
Biederman, Joseph
Venue
The Journal of Clinical Psychiatry
Published
2012-07-15
Volume
73
Issue
07
Pages
941-950
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2030480409
Cited by
291
References
38
Citations by year
2026: 15 · 2025: 10 · 2024: 17 · 2023: 18 · 2022: 15 · 2021: 22 · 2020: 20 · 2019: 25 · 2018: 18 · 2017: 18 · 2016: 33 · 2015: 28 · 2014: 33 · 2013: 17 · 2012: 2
FWCI
18.24
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Massachusetts General Hospital
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
Keywords
attention deficit hyperactivity disorder, adult outcomes, psychopathology, functional disability, antisocial personality disorder, mood disorders, anxiety disorders, substance use disorders, nicotine dependence, school functioning, neuropsychological performance, longitudinal follow-up, early intervention
MeSH terms
Adolescent, Adult, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Educational Status, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Prospective Studies, Quality of Life, Smoking, Socioeconomic Factors, Comorbidity, Case-Control Studies, Mood Disorders, Family Conflict, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review